:::

學術成果

:::
搜尋
年至

月至


  • 關鍵字搜尋
  • 第 1 頁 / 共 3 頁
    1. [上一頁]
    2. 1
    3. 2
    4. 3
    5. [下一頁]
    期刊論文
    學年度著作著作人
    102Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R. ,2013,Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. ,Pharmaceutics,5,1,pp179-200 (SCI)陳建煒
    102Funch D, Holick C, Velentgas P, Clifford R, Wahl PM, McMahill-Walraven C, Gladowski P, Platt R, Amato A, Chan KA.,2013,Algorithms for identification of Guillain Barré Syndrome in claims databases. ,Vaccine,31,12,pp2075-2079 (SCI)陳建煒
    102Kulldorff M, Dashevsky I, Avery T, Chan KA, Davis RL, Graham D, Platt R, Andrade SE, Boudreau D, Gunter MJ, Herrinton LJ, Pawloski P, Raebel MA, Roblin D, Brown JS. ,2013,Drug safety data mining with a tree-based SCAN statistic.,Pharmacoepidemiology and Drug Safety,22,5,pp517-523 (SCI)陳建煒
    102Dong Y-H, Chang C-H, Shau W-Y, Kuo RN, Lai M-S, Chan KA. ,2013,Development and validation of a pharmacy-based comorbidity measure in a population-based automated healthcare database. ,Pharmacotherapy,33,2,pp123-136 (SCI)陳建煒
    1011. Wu, S.J., Kuo, Y.Y.*, Hou, H.A., Li, L.Y., Tseng, M.H., Huang, C.F., Lee, F.Y., Liu, M.C., Liu, C.W., Lin, C.T., Chen, C.Y., Chou, W.C., Yao, M., Huang, S.Y., Ko, B.S., Tang, J.L., Tsay, W., and Tien, H.F.*,2012,The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution.,Blood. ,120,pp3106-3111 (SCI)郭遠燁
    101Hou, H.A.#, Kuo, Y.Y.#, Liu, C.Y., Chou, W.C., Lee, M.C., Chen, C.Y., Lin, L.I., Tseng, M.H., Huang, C.F., Chiang, Y.C., Lee, F.Y., Liu, M.C., Liu, C.W., Tang, J.L., Yao, M., Huang, S.Y., Ko, B.S., Hsu, S.C., Wu, S.J., Tsay, W., Chen, Y.C., Tien, H.F.,2012,DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. ,Blood.,119,2,pp559-568 (SCI)郭遠燁
    101Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R. ,2012,Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination.,Pharmacoepidemiology and Drug Safety,21,12,pp1350-1358 (SCI)陳建煒
    101Dore D, Seeger J, Chan KA.,2012,Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance., Therapeutic Advances in Drug Safety ,3,pp157-164 (SCI)陳建煒
    101Chang C-H, Lin J-W, Wu L-C, Lai M-S, Chuang L-M, Chan KA. ,2012,Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.,Hepatology,55,5,pp1462-1472 (SCI)陳建煒
    1004. Chou, W.C., Chou, S.C., Liu, C.Y., Chen, C.Y., Hou, H.A., Kuo, Y.Y., Lee, M.C., Ko, B.S., Tang, J.L., Yao, M., Tsay, W., Wu, S.J., Huang, S.Y., Hsu, S.C., Chen, Y.C., Chang, Y.C., Kuo, Y.Y., Kuo, K.T., Lee, F.Y., Liu, M.C., Liu, C.W., Tseng, M.H., Huang, C.F., Tien, H.F.,2011,TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.,Blood.,118,pp3803-3810 (SCI)郭遠燁
    第 1 頁 / 共 3 頁
    1. [上一頁]
    2. 1
    3. 2
    4. 3
    5. [下一頁]